HLA-B*35:01 HIV nef 74-81 Tetramer-VPLRPMTY-PE

Catalog No:
MBL-TS-M106-1
$1,470.00

Formerly Catalog No.: TB-M106-1

Description

Product Description

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

Product Specifications
Application FC
Reactivity Human
Conjugation PE
Peptide Sequence VPLRPMTY
Class Class I
Sequence Location 74-81
MHC Allele B*35:01

Documents & Links

Documents & Links for HLA-B*35:01 HIV nef 74-81 Tetramer-VPLRPMTY-PE
Datasheet HLA-B*35:01 HIV nef 74-81 Tetramer-VPLRPMTY-PE Datasheet

Documents & Links for HLA-B*35:01 HIV nef 74-81 Tetramer-VPLRPMTY-PE
Datasheet HLA-B*35:01 HIV nef 74-81 Tetramer-VPLRPMTY-PE Datasheet

Product Description

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

Product Specifications
Application FC
Reactivity Human
Conjugation PE
Peptide Sequence VPLRPMTY
Class Class I
Sequence Location 74-81
MHC Allele B*35:01

Documents & Links

Documents & Links for HLA-B*35:01 HIV nef 74-81 Tetramer-VPLRPMTY-PE
Datasheet HLA-B*35:01 HIV nef 74-81 Tetramer-VPLRPMTY-PE Datasheet

Documents & Links for HLA-B*35:01 HIV nef 74-81 Tetramer-VPLRPMTY-PE
Datasheet HLA-B*35:01 HIV nef 74-81 Tetramer-VPLRPMTY-PE Datasheet